Back to News
Market Impact: 0.25
Moderna Tumbles 10% as Profit Taking Hits Cancer Vaccine Rally; BioNTech Eases, Pfizer Stays Put
Source: 247wallst.com
Healthcare & BiotechMarket Technicals & FlowsInvestor Sentiment & Positioning
Moderna shares fell 10% to $214 as investors took profits in one of biotech’s hottest trades. Selling was heaviest in the stock that had risen the furthest; the article provides no further context or broader market impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.20
Ticker Sentiment
MRNA-0.50
More News
- Meet the New Nasdaq-100 Stock That’s Crushing Nvidia, Micron, and Sandisk. Is It Too Late to Buy?
- Why did CoreWeave stock get crushed this week? Look to this corner of the debt market for clues
- AI stock sell-off ramps up over debt-fueled data center spending fears: ‘Full-blown crisis of confidence'
- Stock fixing scandal could see Turkish companies frozen out of global indexes
- Dow falls 189 points as AI stocks slide and oil prices surge
- Wall Street Anxiety Spreads as AI Rout Meets $110 Oil Shock